Immunotherapy with either antithymocyte globulin (ATG) or antilymphocyte globulin (ALG) is the primary treatment for those children not candidates for bone marrow transplant.

采用抗胸腺细胞球蛋白（ATG）或抗淋巴细胞球蛋白（ALG）免疫疗法是不适宜于骨髓移植患儿的主要治疗方法。